Laidlaw has had a dishonest and misrepresentation behavior. It has damaged the credibility and reputation of Relmada. Those actions have sent stock prices of Relmada going down by a significant percent. Laidlaw later tried to appoint most of the board of directors at Relmada. Everything that Laidlaw did was gross violation of fiduciary laws. Relmada then filed a lawsuit to stop the misinformation. Directors at Relmada are working hard to rebuild the company’s reputation. The company strives to protect its shareholders. The amended lawsuit will seek further protection and restitution. Laidlaw will not win in its actions to take over the company.
Laidlaw and company Ltd. is an investment bank. It has its base operations in New York. It is incorporated in England. The company is led by Mathew Eitner and James Ahern. The two have been infamous for the misinformation. They attempted to undermine Relmada Company by releasing wrong information. Laidlaw is a firm that lacks in compliance. It has violated SEC laws. It has hired rogue investors from investment companies that were shut down.
Relmada Therapeutics is a clinical drug firm. It develops novel therapies for treatment of chronic pain. The company made several lawsuits against Laidlaw. The lawsuits claims that Laidlaw breached its fiduciary agreement by disclosing confidential information.